
AI-powered decisions enable fully automated cell culture of organoids and iPSCs
Friday, October 3, 2025 at 16:00 BST | 17:00 CEST | 11:00 EDT | 8:00 PDT
While cell-based models and assays are basic tools for drug development and biological research, tissue culture remains the most routine, hands-on, and time-consuming part of biological studies. Because of protocol complexity, sensitivity to errors, and substantial training requirements, these processes are difficult to automate and to ensure reproducibility and quality, especially when working with complex cell models such as organoids.
In this SelectScience® webinar, Dr. Oksana Sirenko from Molecular Devices, will present an overview of how AI-powered decision-making and automation create a fully automated cell culture platform. Discover how automation can not only alleviate these time-sensitive and highly routine tasks from the scientist, but can also reduce human error and inconsistencies associated with manual processes.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Speakers


Who should attend?
- Core facility leaders or managers.
- Researchers interested in scaling up their 3D biology workflows.
- Researchers working in high-throughput screening, high-content screening, or toxicology workflows.
What will this webinar cover?
Key learning objectives:
- Explore how automated cell culture can lead to more reproducible assay outcomes
- Discover how automated, AI-powered decision making enables the creation of fully walkaway workflows
- Learn how complex cell models such as organoids, including brain organoids, and iPSCs can be cultured
Join the webinar to get answers to these questions:
- How can automated cell culture improve reproducibility and assay quality?
- In what ways does AI-powered decision-making enable fully walkaway workflows?
- How can complex 3D cell models, including organoids and brain organoids, be reliably cultured?
- What are the benefits of automation for high-throughput and high-content screening workflows?
- How can automation reduce human error and variability in routine tissue culture tasks?
